100% Original Harga Genalten Gentamicin Sulfate - dexamethasone sodium phosphate injection – Xinanran
100% Original Harga Genalten Gentamicin Sulfate - dexamethasone sodium phosphate injection – Xinanran Detail:
[ Adverse reaction ] (1) There were strong water and sodium retention and potassium excretion.
(2) Has strong immunosuppressive effect.
(3) High dose use in late pregnancy might cause abortion.
[ Notice ] (1) It is contra-indicated in pregnant animals at earlier or late stages.
(2) In case of bacterial infections it should be combined with antimicrobial agents.
(3) Long-term medication should not be discontinued suddenly, the dosage gradually reduced until discontinuation.
[Withdrawal period] Cattle, sheep and pigs 21 days; The milk abandonment period is 72 hours.
[ Specification ] (1) 1ml:1mg (2) 5ml:5mg
[Storage] Shading the light and keeping it in a closed manner.
[Period of validity] Two years
[Manufacturing enterprise ] Hebei XinAnRan Biotechnology Co., Ltd
[Factory address] No. 6 First Row East, Konggang Street Economic Development Zone, Xinle City, Hebei Province.
Product detail pictures:
Related Product Guide:
We'll make every effort and hard work being outstanding and excellent, and speed up our techniques for standing during the rank of global top-grade and high-tech enterprises for 100% Original Harga Genalten Gentamicin Sulfate - dexamethasone sodium phosphate injection – Xinanran , The product will supply to all over the world, such as: Berlin, Chicago, Riyadh, Satisfaction and good credit to every customer is our priority. We focus on every detail of order processing for customers till they have received safe and sound solutions with good logistics service and economical cost. Depending on this, our solutions are sold very well in the countries in Africa, the Mid-East and Southeast Asia.
By Daniel Coppin from Nairobi - 2017.06.22 12:49
The company leader recept us warmly, through a meticulous and thorough discussion, we signed a purchase order. Hope to cooperate smoothly
By Barbara from Cancun - 2018.12.11 11:26